Foldamers

	WikiDoc Resources for Foldamers
Articles
Most recent articles on Foldamers Most cited articles on Foldamers Review articles on Foldamers Articles on Foldamers in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Foldamers Images of Foldamers Photos of Foldamers Podcasts & MP3s on Foldamers Videos on Foldamers
Evidence Based Medicine
Cochrane Collaboration on Foldamers Bandolier on Foldamers TRIP on Foldamers
Clinical Trials
Ongoing Trials on Foldamers at Clinical Trials.gov Trial results on Foldamers Clinical Trials on Foldamers at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Foldamers NICE Guidance on Foldamers NHS PRODIGY Guidance FDA on Foldamers CDC on Foldamers
Books
Books on Foldamers
News
Foldamers in the news Be alerted to news on Foldamers News trends on Foldamers
Commentary
Blogs on Foldamers
Definitions
Definitions of Foldamers
Patient Resources / Community
Patient resources on Foldamers Discussion groups on Foldamers Patient Handouts on Foldamers Directions to Hospitals Treating Foldamers Risk calculators and risk factors for Foldamers
Healthcare Provider Resources
Symptoms of Foldamers Causes & Risk Factors for Foldamers Diagnostic studies for Foldamers Treatment of Foldamers
Continuing Medical Education (CME)
CME Programs on Foldamers
International
Foldamers en Espanol Foldamers en Francais
Business
Foldamers in the Marketplace Patents on Foldamers
Experimental / Informatics
List of terms related to Foldamers

Overview

A foldamer is a discrete chain molecule or oligomer that adopts a secondary structure stabilized by non-covalent interactions ^[1] ^[2]. They are artificial molecules that mimic the ability of proteins, nucleic acids, and polysaccharides to fold into well-defined conformations, such as helices and β-sheets. Foldamers have been demonstrated to display a number of interesting supramolecular properties including molecular self-assembly, molecular recognition, and host-guest chemistry. They are studied as models of biological molecules and have been shown to display antimicrobial activity. They also have great potential application to the development of new functional materials.

Examples:

m-Phenylene ethynylene oligomers are driven to fold into a helical conformation by solvophobic forces and aromatic stacking interactions.
β-peptides are composed of amino acids containing an additional methylene unit between the amine and carboxylic acid. They are more stable to enzymatic degradation and have been demonstrated to have antimicrobial activity.
Aedamers that fold in aqueous solutions driven by hydrophobic and aromatic stacking interactions.

Important Reviews:

^ Gellman, S.H. (1998). "Foldamers: a manifesto" (PDF). Acc. Chem. Res. 31 (4): 173–180. doi:10.1021/ar960298r.
^ Hill DJ, Mio MJ, Prince RB, Hughes TS, Moore JS (2001). "A field guide to foldamers". Chem. Rev. 101 (12): 3893–4012. doi:10.1021/cr990120t. PMID 11740924.

"Moore Research Group". Developed m-Phenylene ethynylene oligomers. Retrieved October 15. Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Check date values in: |accessdate= (help)
"Gellman Research Group". Developed a number of β-peptides and has explored their antimicrobial activity. Retrieved October 15. Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Check date values in: |accessdate= (help)
"Iverson Research Group". Developed aedamers that fold in aqueous solutions. Retrieved October 15. Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Check date values in: |accessdate= (help)